Big Gain For Lineage Cell Therapeutics, Inc.

Wed, Apr 28, 2021 at 05:30 PM
Big Gain For Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) rocketted at $43.73, representing a gain of 75.6%. On Tue, Apr 27, 2021, BTX:NYSEMKT hit a New 2-Week High of $24.9. The stock got featured on our News Catalysts scanner on Mon, Apr 26, 2021 at 08:48 AM in the 'MISCELLANEOUS' category. From Tue, Apr 13, 2021, the stock recorded 80.00% Up Days and 54.55% Green Days

About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)

BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.